You have 9 free searches left this month | for more free features.

ABT-620

Showing 1 - 25 of 387

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA))

Completed
  • Heavy Uterine Bleeding
  • Uterine Fibroids
  • (no location specified)
Jul 9, 2021

Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)

Completed
  • Heavy Uterine Bleeding
  • Uterine Fibroids
  • Elagolix placebo
  • +4 more
  • (no location specified)
Jul 7, 2020

Uterine Fibroids Trial in Puerto Rico, United States (Elagolix, Placebo)

Completed
  • Uterine Fibroids
  • Birmingham, Alabama
  • +47 more
Mar 4, 2022

Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix

Active, not recruiting
  • Endometriosis
  • 75 mg linzagolix tablet
  • +5 more
  • Dothan, Alabama
  • +46 more
Jan 12, 2023

Assess Patient-Reported Quality of Life and Effectiveness on

Recruiting
  • Heavy Menstrual Bleeding
  • Uterine Fibroids
    • Durham, North Carolina
      IQVIA RDS, Inc
    Nov 2, 2021

    Oral Elagolix Tablets To Assess Tolerability and Change in

    Recruiting
    • Endometriosis
      • Ramat Gan, Tel-Aviv, Israel
      • +7 more
      Jun 8, 2022

      Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)

      Active, not recruiting
      • Heavy Menstrual Bleeding
      • Uterine Fibroids
      • Elagolix Placebo
      • +3 more
      • Birmingham, Alabama
      • +156 more
      Jan 20, 2022

      Endometriosis Trial (elagolix, )

      Completed
      • Endometriosis
      • (no location specified)
      Sep 14, 2018

      Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone

      Completed
      • Uterine Fibroids
      • Heavy Menstrual Bleeding
      • Birmingham, Alabama
      • +104 more
      Jul 9, 2021

      Endometriosis Trial (, Elagolix)

      Completed
      • Endometriosis
      • (no location specified)
      Aug 9, 2018

      Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

      Completed
      • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
      • Phoenix, Arizona
      • +47 more
      Jun 27, 2022

      Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Birmingham, Alabama
        A. Brent Carter
      Aug 3, 2023

      Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Bowel Trial in Vancouver (Transcutaneous Spinal Cord Stimulation, SHAM

      Recruiting
      • Spinal Cord Injuries
      • +2 more
      • Transcutaneous Spinal Cord Stimulation
      • +2 more
      • Vancouver, British Columbia, Canada
        Blusson Spinal Cord Centre
      Nov 21, 2022

      Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate,

      Completed
      • Uterine Fibroids
      • Heavy Menstrual Bleeding
      • Birmingham, Alabama
      • +123 more
      Jul 9, 2021

      Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)

      Suspended
      • Chronic Spontaneous Urticaria
      • ABT Online Programme
      • Delayed Control group
      • Dublin, Ireland
        St James's Hospital
      Oct 25, 2023

      Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

      Active, not recruiting
      • Chronic Lymphocytic Leucemia
      • Cologne, Germany
        German CLL Study Group
      Sep 14, 2022

      Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

      Active, not recruiting
      • Breast Cancer
      • +3 more
      • Boston, Massachusetts
      • +2 more
      Dec 21, 2022

      Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

      Completed
      • Chronic Lymphocytic Leukemia
      • La Jolla, California
      • +9 more
      Jul 8, 2022

      Osteoarthritis of Hip Trial in Oswestry (Bioguard Group, Control Group)

      Active, not recruiting
      • Osteoarthritis of Hip
      • Bioguard Group
      • Control Group
      • Oswestry, United Kingdom
        RJAH
      Jan 24, 2023

      Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)

      Completed
      • Small Lymphocytic Lymphoma
      • Chronic Lymphocytic Leukemia
      • La Jolla, California
      • +5 more
      Jul 11, 2022

      Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

      Active, not recruiting
      • Rheumatoid Arthritis
      • Placebo for Adalimumab
      • +3 more
      • Birmingham, Alabama
      • +369 more
      Jun 14, 2022

      Crohn's Disease (CD) Trial in Worldwide (ABT-494)

      Active, not recruiting
      • Crohn's Disease (CD)
      • La Jolla, California
      • +60 more
      Sep 8, 2022

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Greenwich, Connecticut
      • +27 more
      Dec 30, 2022

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

      Completed
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +4 more
      • (no location specified)
      Jul 29, 2021